Home2022-05-27T10:10:22-04:00

Disseminating data and research
on Treat All in sub-Saharan Africa

Key data metrics from IeDEA sites in sub-Saharan Africa

  • Enrollment in care

  • Time to ART initiation

  • Pre-treatment CD4 count

  • Viral load suppression

ABOUT THE IeDEA TREAT ALL DASHBOARD

In late 2015, the World Health Organization (WHO) recommended universal treatment of all people living with HIV, regardless of CD4 count or disease stage. WHO’s expanded treatment recommendation—also known as “Treat All”—has dramatically improved access to life-saving treatment around the globe. The purpose of the IeDEA Treat All Dashboard is to disseminate “real world” service delivery data from sites participating in IeDEA, along with research related to Treat All implementation and outcomes.

Read More About Us

WHERE WE ARE

We compile data from HIV care and treatment service delivery sites participating in IeDEA in sub-Saharan Africa, including the subregions of Central, East, Southern and West Africa.

0
IeDEA regions in sub-Saharan Africa
0
Countries
>0
Clinics contributing data to IeDEA

1.4M people living with HIV ever enrolled at care and treatment sites in Africa participating in IeDEA

WHO Treat All guidelines expanded
WHO Treat All guidelines expanded
WHO Treat All guidelines expanded
WHO Treat All guidelines expanded
IeDEA site location

FEATURED DATA VISUALIZATIONS

Timely ART initiation among patients enrolling in care at IeDEA sites
(2010 – 2017)

Central Africa

WHO Treat All guidelines expanded

East Africa

WHO Treat All guidelines expanded

Southern Africa

WHO Treat All guidelines expanded

West Africa

WHO Treat All guidelines expanded
  • Initiated ART within 7 days
  • Initiated ART within 30 days
  • Initiated ART within 12 months
Explore All Data

BLOG

RECENT PUBLICATIONS

Delayed presentation of HIV among older individuals: a growing problem
Lancet HIV | 2022
Justice AC, Goetz MB, Stewart CN, Hogan BC, Humes E, Luz PM, Castilho JL, Nash D, Brazier E, Musick B, Yiannoutsos C, Malateste K, Jaquet A, Cornell M, Shamu T, Rajasuriar R, Jiamsakul A, Althoff KN.
Virologic non-suppression and early loss to follow up among pregnant and non-pregnant adolescents aged 15-19 years initiating antiretroviral therapy in South Africa: a retrospective cohort study
Journal of the International AIDS Society | 2022
Nyakato P, Schomaker M, Fatti G, Tanser F, Euvrard J, Sipambo N, Fox MP, Haas AD, Yiannoutsos CT, Davies MA, Cornell M
Real-world use and outcomes of dolutegravir-containing antiretroviral therapy in HIV and tuberculosis co-infection: a site survey and cohort study in sub-Saharan Africa.
Journal of the International AIDS Society | 2022
Romo ML, Brazier E, Mahambou-Nsondé D, De Waal R, Sekaggya-Wiltshire C, Chimbetete C, Muyindike WR, Murenzi G, Kunzekwenyika C, Tiendrebeogo T, Muhairwe JA, Lelo P, Dzudie A, Twizere C, Rafael I, Ezechi OC, Diero L, Yotebieng M, Fenner L, Wools-Kaloustian KK, Shah NS, Nash D; International epidemiology Databases to Evaluate AIDS (IeDEA).
Clinical and programmatic outcomes of HIV-exposed infants enrolled in care at geographically diverse clinics, 1997-2021: A cohort study.
PLoS Medicine | 2022
Edmonds A, Brazier E, Musick BS, Yotebieng M, Humphrey J, Abuogi LL, Adedimeji A, Keiser O, Msukwa M, Carlucci JG, Maia M, Pinto JA, Leroy V, Davies MA, Wools-Kaloustian KK; IeDEA.
See all publications
WHO Treat All guidelines expanded

SUBSCRIBE TO OUR MAILING LIST


Get the latest updates about the
IeDEA Treat All Dashboard

CONTACT US

feedback@IeDEAdashboard.org

IeDEA REGIONS IN AFRICA

DESIGNED AND DEVELOPED BY

CUNY Institute for Implementation
Science in Population Health and Vanderbilt University Medical College

FUNDED BY

The National Institute of Allergy and Infectious Diseases, National Institutes of Health

RECOMMENDED CITATION

IeDEA Treat All Dashboard. September 2021. Retrieved from www.IeDEAdashboard.org.